1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sepsis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Aminoglycosides 1.2.3 Colony Stimulating Factors 1.2.4 Second Generation Cephalosporins 1.2.5 Third Generation Cephalosporins 1.2.6 Glycopeptide Antibiotics 1.2.7 Inhaled Intifectives 1.2.8 Others 1.3 Market by Application 1.3.1 Global Sepsis Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Sepsis Therapeutics Market Size (2017-2028) 2.2 Sepsis Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Sepsis Therapeutics Market Size by Region (2017-2022) 2.4 Global Sepsis Therapeutics Market Size Forecast by Region (2023-2028) 2.5 Global Top Sepsis Therapeutics Countries Ranking by Market Size 3 Sepsis Therapeutics Competitive by Company 3.1 Global Sepsis Therapeutics Revenue by Players 3.1.1 Global Sepsis Therapeutics Revenue by Players (2017-2022) 3.1.2 Global Sepsis Therapeutics Market Share by Players (2017-2022) 3.2 Global Sepsis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Sepsis Therapeutics Revenue 3.4 Global Sepsis Therapeutics Market Concentration Ratio 3.4.1 Global Sepsis Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sepsis Therapeutics Revenue in 2021 3.5 Global Sepsis Therapeutics Key Players Head office and Area Served 3.6 Key Players Sepsis Therapeutics Product Solution and Service 3.7 Date of Enter into Sepsis Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Sepsis Therapeutics Breakdown Data by Type 4.1 Global Sepsis Therapeutics Historic Revenue by Type (2017-2022) 4.2 Global Sepsis Therapeutics Forecasted Revenue by Type (2023-2028) 5 Global Sepsis Therapeutics Breakdown Data by Application 5.1 Global Sepsis Therapeutics Historic Market Size by Application (2017-2022) 5.2 Global Sepsis Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Sepsis Therapeutics Revenue by Company (2020-2022) 6.2 North America Sepsis Therapeutics Revenue by Type (2017-2028) 6.3 North America Sepsis Therapeutics Revenue by Application (2017-2028) 6.4 North America Sepsis Therapeutics Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Sepsis Therapeutics Revenue by Company (2020-2022) 7.2 Europe Sepsis Therapeutics Revenue by Type (2017-2028) 7.3 Europe Sepsis Therapeutics Revenue by Application (2017-2028) 7.4 Europe Sepsis Therapeutics Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Sepsis Therapeutics Revenue by Company (2020-2022) 8.2 Asia Pacific Sepsis Therapeutics Revenue by Type (2017-2028) 8.3 Asia Pacific Sepsis Therapeutics Revenue by Application (2017-2028) 8.4 Asia Pacific Sepsis Therapeutics Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Sepsis Therapeutics Revenue by Company (2020-2022) 9.2 Latin America Sepsis Therapeutics Revenue by Type (2017-2028) 9.3 Latin America Sepsis Therapeutics Revenue by Application (2017-2028) 9.4 Latin America Sepsis Therapeutics Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Sepsis Therapeutics Revenue by Company (2020-2022) 10.2 Middle East and Africa Sepsis Therapeutics Revenue by Type (2017-2028) 10.3 Middle East and Africa Sepsis Therapeutics Revenue by Application (2017-2028) 10.4 Middle East and Africa Sepsis Therapeutics Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Agennix 11.1.1 Agennix Company Details 11.1.2 Agennix Business Overview 11.1.3 Agennix Sepsis Therapeutics Products and Services 11.1.4 Agennix Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.1.5 Agennix Sepsis Therapeutics SWOT Analysis 11.1.6 Agennix Recent Developments 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Sepsis Therapeutics Products and Services 11.2.4 AstraZeneca Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.2.5 AstraZeneca Sepsis Therapeutics SWOT Analysis 11.2.6 AstraZeneca Recent Developments 11.3 Atox Bio 11.3.1 Atox Bio Company Details 11.3.2 Atox Bio Business Overview 11.3.3 Atox Bio Sepsis Therapeutics Products and Services 11.3.4 Atox Bio Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.3.5 Atox Bio Sepsis Therapeutics SWOT Analysis 11.3.6 Atox Bio Recent Developments 11.4 CytoGenix 11.4.1 CytoGenix Company Details 11.4.2 CytoGenix Business Overview 11.4.3 CytoGenix Sepsis Therapeutics Products and Services 11.4.4 CytoGenix Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.4.5 CytoGenix Sepsis Therapeutics SWOT Analysis 11.4.6 CytoGenix Recent Developments 11.5 Eli Lilly 11.5.1 Eli Lilly Company Details 11.5.2 Eli Lilly Business Overview 11.5.3 Eli Lilly Sepsis Therapeutics Products and Services 11.5.4 Eli Lilly Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.5.5 Eli Lilly Sepsis Therapeutics SWOT Analysis 11.5.6 Eli Lilly Recent Developments 11.6 Endacea 11.6.1 Endacea Company Details 11.6.2 Endacea Business Overview 11.6.3 Endacea Sepsis Therapeutics Products and Services 11.6.4 Endacea Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.6.5 Endacea Sepsis Therapeutics SWOT Analysis 11.6.6 Endacea Recent Developments 11.7 NexBio 11.7.1 NexBio Company Details 11.7.2 NexBio Business Overview 11.7.3 NexBio Sepsis Therapeutics Products and Services 11.7.4 NexBio Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.7.5 NexBio Sepsis Therapeutics SWOT Analysis 11.7.6 NexBio Recent Developments 11.8 Medinox 11.8.1 Medinox Company Details 11.8.2 Medinox Business Overview 11.8.3 Medinox Sepsis Therapeutics Products and Services 11.8.4 Medinox Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) 11.8.5 Medinox Sepsis Therapeutics SWOT Analysis 11.8.6 Medinox Recent Developments 12 Sepsis Therapeutics Market Dynamics 12.1 Sepsis Therapeutics Market Trends 12.2 Sepsis Therapeutics Market Drivers 12.3 Sepsis Therapeutics Market Challenges 12.4 Sepsis Therapeutics Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Sepsis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Aminoglycosides Table 3. Key Players of Colony Stimulating Factors Table 4. Key Players of Second Generation Cephalosporins Table 5. Key Players of Third Generation Cephalosporins Table 6. Key Players of Glycopeptide Antibiotics Table 7. Key Players of Inhaled Intifectives Table 8. Key Players of Others Table 9. Global Sepsis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 10. Global Sepsis Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 11. Global Sepsis Therapeutics Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Sepsis Therapeutics Revenue Market Share by Region (2017-2022) Table 13. Global Sepsis Therapeutics Revenue by Players (2017-2022) & (US$ Million) Table 14. Global Sepsis Therapeutics Market Share by Players (2017-2022) Table 15. Global Top Sepsis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2021) Table 16. Ranking of Global Top Sepsis Therapeutics Companies by Revenue (US$ Million) in 2021 Table 17. Global 5 Largest Players Market Share by Sepsis Therapeutics Revenue (CR5 and HHI) & (2017-2022) Table 18. Key Players Headquarters and Area Served Table 19. Key Players Sepsis Therapeutics Product Solution and Service Table 20. Date of Key Manufacturers Enter into Sepsis Therapeutics Market Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Sepsis Therapeutics Market Size by Type (2017-2022) & (US$ Million) Table 23. Global Sepsis Therapeutics Revenue Market Share by Type (2017-2022) Table 24. Global Sepsis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 25. Global Sepsis Therapeutics Revenue Market Share by Type (2023-2028) Table 26. Global Sepsis Therapeutics Market Size by Application (2017-2022) & (US$ Million) Table 27. Global Sepsis Therapeutics Revenue Market Share by Application (2017-2022) Table 28. Global Sepsis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 29. Global Sepsis Therapeutics Revenue Market Share by Application (2023-2028) Table 30. North America Sepsis Therapeutics Revenue by Company (2020-2022) & (US$ Million) Table 31. North America Sepsis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 32. North America Sepsis Therapeutics Revenue by Type (2023-2028) & (US$ Million) Table 33. North America Sepsis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 34. North America Sepsis Therapeutics Revenue by Application (2023-2028) & (US$ Million) Table 35. North America Sepsis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 36. North America Sepsis Therapeutics Revenue by Country (2023-2028) & (US$ Million) Table 37. Europe Sepsis Therapeutics Revenue by Company (2020-2022) & (US$ Million) Table 38. Europe Sepsis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 39. Europe Sepsis Therapeutics Revenue by Type (2023-2028) & (US$ Million) Table 40. Europe Sepsis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 41. Europe Sepsis Therapeutics Revenue by Application (2023-2028) & (US$ Million) Table 42. Europe Sepsis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 43. Europe Sepsis Therapeutics Revenue by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Sepsis Therapeutics Revenue by Company (2020-2022) & (US$ Million) Table 45. Asia Pacific Sepsis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Sepsis Therapeutics Revenue by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Sepsis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Sepsis Therapeutics Revenue by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Sepsis Therapeutics Revenue by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Sepsis Therapeutics Revenue by Region (2023-2028) & (US$ Million) Table 51. Latin America Sepsis Therapeutics Revenue by Company (2020-2022) & (US$ Million) Table 52. Latin America Sepsis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 53. Latin America Sepsis Therapeutics Revenue by Type (2023-2028) & (US$ Million) Table 54. Latin America Sepsis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 55. Latin America Sepsis Therapeutics Revenue by Application (2023-2028) & (US$ Million) Table 56. Latin America Sepsis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 57. Latin America Sepsis Therapeutics Revenue by Country (2023-2028) & (US$ Million) Table 58. Middle East and Africa Sepsis Therapeutics Revenue by Company (2020-2022) & (US$ Million) Table 59. Middle East and Africa Sepsis Therapeutics Revenue by Type (2017-2022) & (US$ Million) Table 60. Middle East and Africa Sepsis Therapeutics Revenue by Type (2023-2028) & (US$ Million) Table 61. Middle East and Africa Sepsis Therapeutics Revenue by Application (2017-2022) & (US$ Million) Table 62. Middle East and Africa Sepsis Therapeutics Revenue by Application (2023-2028) & (US$ Million) Table 63. Middle East and Africa Sepsis Therapeutics Revenue by Country (2017-2022) & (US$ Million) Table 64. Middle East and Africa Sepsis Therapeutics Revenue by Country (2023-2028) & (US$ Million) Table 65. Agennix Company Details Table 66. Agennix Business Overview Table 67. Agennix Sepsis Therapeutics Product and Services Table 68. Agennix Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 69. Agennix Sepsis Therapeutics SWOT Analysis Table 70. Agennix Recent Developments Table 71. AstraZeneca Company Details Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Sepsis Therapeutics Product and Services Table 74. AstraZeneca Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 75. AstraZeneca Sepsis Therapeutics SWOT Analysis Table 76. AstraZeneca Recent Developments Table 77. Atox Bio Company Details Table 78. Atox Bio Business Overview Table 79. Atox Bio Sepsis Therapeutics Product and Services Table 80. Atox Bio Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 81. Atox Bio Sepsis Therapeutics SWOT Analysis Table 82. Atox Bio Recent Developments Table 83. CytoGenix Company Details Table 84. CytoGenix Business Overview Table 85. CytoGenix Sepsis Therapeutics Product and Services Table 86. CytoGenix Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 87. CytoGenix Sepsis Therapeutics SWOT Analysis Table 88. CytoGenix Recent Developments Table 89. Eli Lilly Company Details Table 90. Eli Lilly Business Overview Table 91. Eli Lilly Sepsis Therapeutics Product and Services Table 92. Eli Lilly Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 93. Eli Lilly Sepsis Therapeutics SWOT Analysis Table 94. Eli Lilly Recent Developments Table 95. Endacea Company Details Table 96. Endacea Business Overview Table 97. Endacea Sepsis Therapeutics Product and Services Table 98. Endacea Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 99. Endacea Sepsis Therapeutics SWOT Analysis Table 100. Endacea Recent Developments Table 101. NexBio Company Details Table 102. NexBio Business Overview Table 103. NexBio Sepsis Therapeutics Product and Services Table 104. NexBio Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 105. NexBio Sepsis Therapeutics SWOT Analysis Table 106. NexBio Recent Developments Table 107. Medinox Company Details Table 108. Medinox Business Overview Table 109. Medinox Sepsis Therapeutics Product and Services Table 110. Medinox Sepsis Therapeutics Revenue in Sepsis Therapeutics Business (2017-2022) & (US$ Million) Table 111. Medinox Sepsis Therapeutics SWOT Analysis Table 112. Medinox Recent Developments Table 113. Sepsis Therapeutics Market Trends Table 114. Sepsis Therapeutics Market Drivers Table 115. Sepsis Therapeutics Market Challenges Table 116. Sepsis Therapeutics Market Restraints Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Global Sepsis Therapeutics Sales Market Share by Type: 2021 VS 2028 Figure 2. Aminoglycosides Features Figure 3. Colony Stimulating Factors Features Figure 4. Second Generation Cephalosporins Features Figure 5. Third Generation Cephalosporins Features Figure 6. Glycopeptide Antibiotics Features Figure 7. Inhaled Intifectives Features Figure 8. Others Features Figure 9. Global Sepsis Therapeutics Sales Market Share by Application: 2021 VS 2028 Figure 10. Hospitals Case Studies Figure 11. Clinics Case Studies Figure 12. Other Case Studies Figure 13. Sepsis Therapeutics Report Years Considered Figure 14. Global Sepsis Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Sepsis Therapeutics Market Size 2017-2028 (US$ Million) Figure 16. Global Sepsis Therapeutics Market Size Market Share by Region: 2021 VS 2028 Figure 17. Global Sepsis Therapeutics Revenue Market Share by Region in 2017 VS 2022 Figure 18. Global Top 10 Sepsis Therapeutics Countries Ranking by Market Size (US$ Million) in 2021 Figure 19. Global Sepsis Therapeutics Market Share by Players in 2021 Figure 20. Global Top Sepsis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Therapeutics as of 2021) Figure 21. The Top 10 and 5 Players Market Share by Sepsis Therapeutics Revenue in 2021 Figure 22. North America Sepsis Therapeutics Revenue Market Share by Company in 2021 Figure 23. North America Sepsis Therapeutics Revenue Market Share by Type (2017-2028) Figure 24. North America Sepsis Therapeutics Revenue Market Share by Application (2017-2028) Figure 25. North America Sepsis Therapeutics Revenue Share by Country (2017-2028) Figure 26. U.S. Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 27. Canada Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 28. Europe Sepsis Therapeutics Revenue Market Share by Company in 2021 Figure 29. Europe Sepsis Therapeutics Revenue Market Share by Type (2017-2028) Figure 30. Europe Sepsis Therapeutics Revenue Market Share by Application (2017-2028) Figure 31. Europe Sepsis Therapeutics Revenue Share by Country (2017-2028) Figure 32. Germany Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 33. France Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 34. U.K. Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 35. Italy Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 36. Russia Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 37. Asia Pacific Sepsis Therapeutics Revenue Market Share by Company in 2021 Figure 38. Asia Pacific Sepsis Therapeutics Revenue Market Share by Type (2017-2028) Figure 39. Asia Pacific Sepsis Therapeutics Revenue Market Share by Application (2017-2028) Figure 40. Asia Pacific Sepsis Therapeutics Revenue Share by Region (2017-2028) Figure 41. China Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 42. Japan Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 43. South Korea Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 44. India Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 45. Australia Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 46. Taiwan Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 47. Indonesia Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 48. Thailand Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 49. Malaysia Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 50. Philippines Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 51. Vietnam Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 52. Latin America Sepsis Therapeutics Revenue Market Share by Company in 2021 Figure 53. Latin America Sepsis Therapeutics Revenue Market Share by Type (2017-2028) Figure 54. Latin America Sepsis Therapeutics Revenue Market Share by Application (2017-2028) Figure 55. Latin America Sepsis Therapeutics Revenue Share by Country (2017-2028) Figure 56. Mexico Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 57. Brazil Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 58. Argentina Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 59. Middle East and Africa Sepsis Therapeutics Revenue Market Share by Company in 2021 Figure 60. Middle East and Africa Sepsis Therapeutics Revenue Market Share by Type (2017-2028) Figure 61. Middle East and Africa Sepsis Therapeutics Revenue Market Share by Application (2017-2028) Figure 62. Middle East and Africa Sepsis Therapeutics Revenue Share by Country (2017-2028) Figure 63. Turkey Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 64. Saudi Arabia Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 65. UAE Sepsis Therapeutics Revenue (2017-2028) & (US$ Million) Figure 66. Agennix Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 67. AstraZeneca Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 68. Atox Bio Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 69. CytoGenix Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 70. Eli Lilly Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 71. Endacea Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 72. NexBio Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 73. Medinox Revenue Growth Rate in Sepsis Therapeutics Business (2017-2022) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Agennix AstraZeneca Atox Bio CytoGenix Eli Lilly Endacea NexBio Medinox